jetcityimage
CVS Health’s (NYSE:CVS) turnaround could be long and arduous, if it resembles that of drugstore rival Walgreens Boots Alliance (NASDAQ:WBA).
Earlier Friday, CVS (CVS) issued a Q3 profit warning and announced it was replacing CEO Karen Lynch with